by Messenger RNA (mRNA) synthesis service involves custom production of mRNA molecules that correspond to specific gene sequences for therapeutic development and research applications. mRNA therapies are being explored for treating a wide range of diseases including cancer, genetic disorders, and infectious diseases. Increasing R&D investments in mRNA vaccines and therapeutic development is fueling the demand for custom mRNA synthesis services. Continuous advancements are being made to optimize mRNA sequence design, delivery techniques, and expression of encoded proteins in the target cells or tissues.
The global m-RNA synthesis service market is estimated to be valued at US$ 6,438.6 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers for the growth of m-RNA synthesis service market is the increasing demand for custom m-RNA production for therapeutics and research applications. Development of novel mRNA drugs and vaccines require significant development efforts, specialized equipment and expertise to synthesize and optimize mRNA sequences. This is driving increased outsourcing of m-RNA synthesis needs to specialist contract development and manufacturing organizations. The success of COVID-19 mRNA vaccines has further accelerated R&D in novel mRNA technologies and their applications. Advancements are being made to enhance the stability, translation efficiency and tissue targeting ability of mRNA molecules. This is expanding the potential of mRNA therapies to new disease areas and driving demand for streamlined custom mRNA synthesis services.
Segment Analysis
The m-RNA synthesis service market size is segmented into in vitro mRNA synthesis and in vivo mRNA synthesis. The in vitro mRNA synthesis segment is dominating the market as it helps in generating mRNA based therapeutics against various diseases which has gained popularity in last few years. The in vitro process allows synthesis of custom designed mRNA outside the body (in vitro) which gives more control over production.
Pest Analysis
Political: The market is positively impacted by rising government support and investment for development of new therapeutic techniques like mRNA therapies. Economic: Increasing investment by companies in R&D of mRNA based drugs and services is fueling market growth. social: Rising awareness about personalized medicine and need for advanced therapeutics is driving demand for mRNA synthesis services. Technological: Advancements in mRNA synthesis techniques such as modified RNA bases, capping and stabilization allow generation of more effective mRNA which boost the market.
Key Takeaways
The Global M-RNA Synthesis Service Market Size is expected to witness high growth over the forecast period given the ongoing research and development of mRNA based vaccines and drugs along with rising economic growth.
Regional analysis: North America accounts for the largest share in the market due to presence of leading players and availability of latest technologies. Easy availability of funding from government and private sectors boosts research in the region. Asia pacific is expected to be the fastest growing market led by countries like china and India due to increasing government support for healthcare industry.
Key players: Key players operating in the m-RNA synthesis service market are Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company. Key players like Maravai LifeSciences and Creative Biolabs are focusing on expanding their service capabilities as well as developing new customized mRNA synthesis platforms which has helped them gain significant market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
